ArticleAging clinical and experimental research2026
Longitudinal monitoring of denosumab-associated bone changes by REMS in postmenopausal women with ER-positive breast cancer receiving aromatase inhibitors.
Carla Caffarelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.